ADNRX
Price
$16.55
Change
-$1.00 (-5.70%)
Updated
Feb 21 closing price
Net Assets
195.39M
RRMGX
Price
$87.45
Change
-$1.84 (-2.06%)
Updated
Feb 21 closing price
Net Assets
29.49B
Ad is loading...

ADNRX vs RRMGX

Header iconADNRX vs RRMGX Comparison
Open Charts ADNRX vs RRMGXBanner chart's image
American Beacon ARK Transfmt Innov R6
Price$16.55
Change-$1.00 (-5.70%)
VolumeN/A
Net Assets195.39M
T. Rowe Price Mid-Cap Growth R
Price$87.45
Change-$1.84 (-2.06%)
VolumeN/A
Net Assets29.49B
ADNRX vs RRMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ADNRX vs. RRMGX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RRMGX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 29.5B vs. ADNRX (195M). ADNRX (0.00) and RRMGX (0.00) have matching dividends . ADNRX was incepted earlier than RRMGX: ADNRX (4 years) vs RRMGX (22 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RRMGX (21.70). ADNRX has a lower initial minimum investment than RRMGX: ADNRX (0) vs RRMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 24.91 vs. RRMGX (-6.96).
ADNRXRRMGXADNRX / RRMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence4 years22 years-
Gain YTD6.158-0.535-1,152%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets195M29.5B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year24.91-6.96-358%
Returns for 3 years-11.07-4.36254%
Returns for 5 yearsN/A-4.19-
Returns for 10 yearsN/A14.90-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATR146.34-0.34
-0.23%
AptarGroup
UFCS25.47-0.73
-2.79%
United Fire Group
KRMD3.71-0.17
-4.38%
KORU Medical Systems
SHO10.65-0.65
-5.75%
Sunstone Hotel Investors
WINT4.35-0.45
-9.38%
Windtree Therapeutics Inc.